PHILADELPHIA, PA, United States of America

Federico Mingozzi

This inventor holds 4 USPTO granted patents and 20 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Genethon, Sorbonne Université, Université D'evry-Val-D'essonne. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Federico Mingozzi. Retrieved from https://idiyas.com/inventor/federico-mingozzi-k1km7n0z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 4 (Patent Applications = 20)

% Patents Active = 50.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 14)

Average Co-Inventor Count = 2.8

ph-index = 1

Company Filing History:

Université D'evry-Val-D'essonne

patents

4. 2 out of 24

Association Institut De Myologie

patents

5. 1 out of 5,383

Centre National De La Recherche Scientifique

patents

6. 1 out of 22

Inserm (Institut National De La Santé Et De La Recherche Médicale)

patents

7. 1 out of 13

Institut National De La Sante Et De La Recherche Medicale

patents

8. 1 out of 1,853

National Institute of Health and Medical Research

patents

9. 1 out of 301

The Children's Hospital of Philadelphia

patents

where one patent can have more than one assignee

Years Active: 2024-2026

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662512 - CHIMERIC POLYPEPTIDES AND USES THEREOF (2026-06-23),

2. 12637668 - MINI-GDE FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE III (2026-05-26),

3. 12305187 - Acid-alpha glucosidase variants and uses thereof (2025-05-20),

4. 11939590 - AAV vector compositions and methods for gene transfer to cells, organs and tissues (2024-03-26),

Title: Inventor Federico Mingozzi: Revolutionizing Innovation in Philadelphia

Introduction: Federico Mingozzi is a pioneering inventor based in Philadelphia, PA, known for his groundbreaking contributions to the field of biotechnology and gene therapy.

Latest Patents: Federico Mingozzi holds several patents in the areas of gene therapy delivery systems, viral vectors, and genetic engineering techniques, with his most recent patent focusing on a novel method for targeted gene editing in specific cell types.

Career Highlights: With a background in molecular biology and genetics, Federico Mingozzi has had a distinguished career working in both academic research institutions and biotechnology companies. He has been instrumental in developing cutting-edge therapies for genetic disorders and has received numerous accolades for his innovative work.

Collaborations: Throughout his career, Federico Mingozzi has collaborated with leading scientists, researchers, and pharmaceutical companies to advance the field of gene therapy. His collaborative efforts have resulted in significant advancements in the treatment of rare genetic diseases.

Conclusion: Federico Mingozzi's passion for innovation and his dedication to improving the lives of patients through gene therapy have solidified his reputation as a visionary inventor in the biotechnology industry. His work continues to inspire the next generation of inventors and researchers in Philadelphia and beyond.

Profile summary based on public USPTO records.